No Detail Found!

Epidemiology and Clinical Advancements in Managing and Treating Diabetes Mellitus

Author(s)
Mohammed Shaikhomer Department of Internal Medicine, Faculty of Medicine, King Abdulaziz University,Jeddah,Saudi Arabia
Abstract
Type 2 diabetes (T2D) is a highly prevalent metabolic disorder which manifests as a result of numerous genetic, epigenetic and life-style factors. According to the estimates of the World Health Organization, about 90% of diabetic patients suffer from T2D. It can be managed by appropriate medication (oral medications and/or insulin) and lifestyle changes including low carbohydrate diet and regular exercise. Mounting evidence suggests that T2D is associated with increased risk of certain cancer including liver, breast, colorectal, pancreatic, endometrial and bladder. However, evidence for the connection between T2D and other cancers such as esophageal cancer and kidney cancer is relatively less conclusive. While the molecular mechanisms linking T2D and cancer are incompletely understood, anti-diabetic drugs are known to have differential effects in cancer patients with T2D. For example, insulin promotes cell proliferation and emergence of chemoresistant whereas metformin suppresses tumor growth. Therefore, an in-depth understanding of molecular factors that link T2D with cancer is crucial for selecting an appropriate anti-hyperglycemic medication for cancer patients suffering from T2D. The current review highlights the potential molecular interactions which play a critical role in metabolic alterations in cancer patients with T2D as well as possible therapeutic strategies that may significantly contribute to the successful management of cancer in patients with diabetic complications.
Publication Details
Page(s) 1417-1424
Published Journal: Pakistan Journal of Life and Social Sciences, Volume: 23, Issue: 1, Year: 2025

Request the full text from PASTIC

Keywords
Biomarkers Cancer Diabetes Management Metabolism
References
Janić M,Janež A,El-Tanani M,Maggio V,Rizzo M .2024 .. Diabetes: Recent Advances and Future Perspectives. Biomedicines, 12(12) : 2875.
Alshaikh AA,Al-Qahtani FS,Taresh HMN,Hayaza RAA,Alqhtani SSM,Summan SI,Al Mansour SA,Alsultan OHA,Asiri HYM,Alqahtani YMS .2024 .Prediction of Diabetes and Prediabetes among the Saudi Population Using a Non-Invasive Tool (AUSDRISK). Medicina, 60(5) : 775.
Chandrasekaran P,Weiskirchen R .1882 .The Role of Obesity in Type 2 Diabetes Mellitus-An Overview. International Journal of Molecular Sciences, 25(3) : .
Boyle JA,Reja A,Lee WK,Chen M,Ko MSM,Alycia C,Kwon J,Lim S.,Mokhele T.,Prevalence T.,ijerph21111537 Bergman M,Manco M,Satman I,Chan J,Schmidt MI,Sesti G,Vanessa Fiorentino T,AbdulGhani M,Jagannathan R,Gabriel R,Mohan V,Buysschaert M,Bennakhi A,Pascal Kengne A,Dorcely B,Nilsson PM,Tuomi T,Battelino T,Hussain A,Ceriello A,Tuomilehto J .2024 .International Diabetes Federation Position Statement on the 1-hour post-load plasma glucose for the diagnosis of intermediate hyperglycaemia and type 2 diabetes. Diabetes Res Clin Pract, 209(11) : 111589.
.2020 .Epub 2020 Jun 1. Erratum in: Diabetes Res Clin Pract, 180 : 108632.
Holt R.I.G.,Cockram C.S.,R.C.W. Diabetes C.S. .2024 .and infection: review of the epidemiology, mechanisms and principles of treatment. Diabetologia, 67 : 1168-1180.
Ekwebene O.C.,Mensah E.A.,Ekwebene C.F. .2024 .Prevalence and predictors of cancer among diabetic individuals in the United States. Discov Epidemics, 1(3) : .
Tkaczenko H.,Kamiński P.,Kurhaluk N. .2024 .Diabetes Mellitus and the Risk of Carcinogenesis: An Interdisciplinary Approach. , : .
Springer . .. , : 426.
Gu J.,Lu H.,Chen C. .2021 .Diabetes mellitus as a risk factor for chemotherapy-induced peripheral neuropathy: a meta-analysis. Support Care Cancer, 29 : 7461-7469.
Hadgu A.,Yan F.,Mayberry R. .2024 .The Association Between Vitamin D Deficiency and Diabetes in Adult African Americans and Whites: An NHANES Study. J. Racial and Ethnic Health Disparities, : .
Waris G,Ahsan H . .Reactive oxygen species: role in the development of cancer and various chronic conditions. 2006 May, 11 : 14.
Srinivas US,Tan BWQ,Vellayappan BA,Jeyasekharan AD .2019 .ROS and the DNA damage response in cancer. Redox Biol, 25 : 101084.
. .Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements. Biomolecules. 2019 Nov, 13(11) : 735.
Jiang X,Wang X .2004 .Cytochrome C-mediated apoptosis. Annu Rev Biochem, 73 : 87-106.
Shen S.,Shao Y.,Li C. .2023 .Different types of cell death and their shift in shaping disease. Cell Death Discov. 9, (284) : .
Popko K,Gorska E,Stelmaszczyk-Emmel A,Plywaczewski R,Stoklosa A,Gorecka D,Pyrzak B,Demkow U . .Proinflammatory cytokines Il-6 and TNF-α and the development of inflammation in obese subjects. Eur J Med Res. 2010 Nov, 4(Suppl 2) : 120-2.
Tylutka A,Walas Ł,Zembron-Lacny A . .Level of IL-6, TNF, and IL-1β and age-related diseases: a systematic review and meta-analysis. 2024 Mar, 1 : 1330386.
Pantovic-Stefanovic M.,Velimirovic M.,Jurisic V. .2024 .Exploring the role of TNF-α, TGF-β, and IL6 serum levels in categorical and noncategorical models of mood and psychosis. Sci Rep, 14(23117) : .
.2010 .Afanas'ev I. Signaling of reactive oxygen and nitrogen species in Diabetes mellitus. Oxid Med Cell Longev, 3(6) : 361-73.
SM Son .2012 .Reactive oxygen and nitrogen species in pathogenesis of vascular complications of diabetes. Diabetes Metab J, 36(3) : 190-8.
Yu Y,Li W,Xu L,Wang Y .2023 .Circadian rhythm of plasminogen activator inhibitor-1 and cardiovascular complications in type 2 diabetes. Front. Endocrinol, 14 : 1124353.
Yarmolinsky J.,Barbieri Bordin,Weinmann N.,T. N. .2016 .Plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and meta-analysis of observational studies. Sci Rep, 6(17714) : .
Tchernof A,Mansour MF,Pelletier M,Boulet MM,Nadeau M,Luu-The V .2015 .Updated survey of the steroid-converting enzymes in human adipose tissues. J Steroid Biochem Mol Biol, 147 : 56-69.
Zhang J,Yin J,Song X,Lai S,Zhong S,Jia Y. .2023 .The effect of exogenous estrogen on depressive mood in women: A systematic review and meta-analysis of randomized controlled trials. J Psychiatr Res, 162 : 21-29.
Hugh JC,Haddon LSJ,Githaka JM .2024 .DREAM Off: A Review of the Estrogen Paradox in Luminal A Breast Cancers. Biomedicines, 12(6) : 1300.
Kranjčević J-K J,Ozretić P .2024 .The Role of Estrogen and Estrogen Receptors in Head and Neck Tumors. Cancers, 16(8) : 1575.
Aloke C,Egwu CO,Aja PM,Obasi NA,Chukwu J,Akumadu BO,Ogbu PN,Achilonu I. Current .2022 .Advances in the Management of Diabetes Mellitus. Biomedicines, 10(10) : 2436.
Elkhalifa AME,Nazar M,Ali SI,Khursheed I,Taifa S,Ahmad Mir M,Shah IH,Malik M,Ramzan Z,Ahad S .2024 .Novel Therapeutic Agents for Management of Diabetes Mellitus: A Hope for Drug Designing against Diabetes Mellitus. Life, 14(1) : 99.
Kounatidis D,Vallianou NG,Karampela I,Rebelos E,Kouveletsou M,Dalopoulos V,Koufopoulos P,Diakoumopoulou E,Tentolouris N,Dalamaga M.,Anti-Diabetic Therapies M. .2024 .Cancer: From Bench to Bedside. , 14(11) : 1479.
Shouman M,Brabant M,Rehman N,Ahmed S,Shahid RK .2024 .Perioperative Management of Patients with Diabetes and Cancer: Challenges and Opportunities. , 16(16) : 2821.
0

Citations

0

Downloads

75

Views